Surgical resection and liver transplantation for hepatocellular carcinoma
- PMID: 25921669
- DOI: 10.1016/j.cld.2015.01.007
Surgical resection and liver transplantation for hepatocellular carcinoma
Abstract
With a better understanding of the natural history of hepatocellular carcinoma (HCC) and the improvement in imaging, locoregional therapies, surgical techniques, and postoperative care, patients with HCC are now managed by a multidisciplinary team. Partial hepatic resection can be curative in patients developing HCC in the setting of normal liver parenchyma and in patients with early cirrhosis but well-preserved hepatic synthetic function. Liver transplantation offers the best long-term survival and lowest incidence of tumor recurrence in select patients with HCC and underlying cirrhosis. This article discusses the role of surgical resection and liver transplantation in the management of HCC.
Keywords: Downstaging; Hepatic resection; Hepatocellular carcinoma; Liver transplantation; Living donor liver transplantation; Locoregional therapy.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Liver transplantation for hepatocellular carcinoma.J Hepatobiliary Pancreat Surg. 2008;15(2):124-30. doi: 10.1007/s00534-007-1296-4. Epub 2008 Apr 6. J Hepatobiliary Pancreat Surg. 2008. PMID: 18392704
-
Resection and liver transplantation for hepatocellular carcinoma.Semin Liver Dis. 2005;25(2):181-200. doi: 10.1055/s-2005-871198. Semin Liver Dis. 2005. PMID: 15918147 Review.
-
Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.Transplant Proc. 2012 Mar;44(2):403-8. doi: 10.1016/j.transproceed.2012.01.067. Transplant Proc. 2012. PMID: 22410028
-
Current management of hepatocellular carcinoma.Med Clin North Am. 2009 Jul;93(4):885-900, viii. doi: 10.1016/j.mcna.2009.03.004. Med Clin North Am. 2009. PMID: 19577120 Review.
-
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.Liver Transpl. 2005 Dec;11(12):1505-14. doi: 10.1002/lt.20526. Liver Transpl. 2005. PMID: 16315294
Cited by
-
Repeat hepatectomy versus thermal ablation therapy for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.Front Oncol. 2024 Mar 28;14:1370390. doi: 10.3389/fonc.2024.1370390. eCollection 2024. Front Oncol. 2024. PMID: 38606103 Free PMC article. Review.
-
Recurrence risk stratification of hepatocellular carcinomas based on immune gene expression and features extracted from pathological images.PLoS Comput Biol. 2023 Dec 29;19(12):e1011716. doi: 10.1371/journal.pcbi.1011716. eCollection 2023 Dec. PLoS Comput Biol. 2023. PMID: 38157378 Free PMC article.
-
Transplant Oncology: An Emerging Discipline of Cancer Treatment.Cancers (Basel). 2023 Nov 9;15(22):5337. doi: 10.3390/cancers15225337. Cancers (Basel). 2023. PMID: 38001597 Free PMC article. Review.
-
Bench-to-bedside development of multifunctional flexible embolic agents.Theranostics. 2023 Apr 1;13(7):2114-2139. doi: 10.7150/thno.80213. eCollection 2023. Theranostics. 2023. PMID: 37153738 Free PMC article. Review.
-
A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.Br J Radiol. 2023 Mar 1;96(1144):20220739. doi: 10.1259/bjr.20220739. Epub 2023 Mar 6. Br J Radiol. 2023. PMID: 36877238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
